Achievement and Safety of a Low Blood Pressure Goal in Chronic Renal Disease: The Modification of Diet in Renal Disease Study Group
The Modification of Diet in Renal Disease Study showed a beneficial effect of a lower-than-usual blood pressure (BP) goal on the progression of renal disease in patients with proteinuria. The purpose of the present analyses was to examine the achieved BP, baseline characteristics that helped or hind...
Gespeichert in:
Veröffentlicht in: | Hypertension (Dallas, Tex. 1979) Tex. 1979), 1997-02, Vol.29 (2), p.641-650 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 650 |
---|---|
container_issue | 2 |
container_start_page | 641 |
container_title | Hypertension (Dallas, Tex. 1979) |
container_volume | 29 |
creator | Lazarus, J. Michael Bourgoignie, Jacques J Buckalew, Vardaman M Greene, Tom Levey, Andrew S Milas, N. Carole Paranandi, Lata Peterson, John C Porush, Jerome G Rauch, Sally Soucie, J. Michael Stollar, Carol |
description | The Modification of Diet in Renal Disease Study showed a beneficial effect of a lower-than-usual blood pressure (BP) goal on the progression of renal disease in patients with proteinuria. The purpose of the present analyses was to examine the achieved BP, baseline characteristics that helped or hindered achievement of the BP goals, and safety of the BP interventions. Five hundred eighty-five patients with baseline glomerular filtration rate between 13 and 55 mL/min per 1.73 m () (0.22 to 0.92 mL/s per 1.73 m) were randomly assigned to either a usual or low BP goal (mean arterial pressure less or equal to 107 or less or equal to 92 mm Hg, respectively). Few patients had a history of cardiovascular disease. All antihypertensive agents were permitted, but angiotensin-converting enzyme inhibitors (with or without diuretics) followed by calcium channel blockers were preferred. The mean (+/- SD) of the mean arterial pressures during follow-up in the low and usual BP groups was 93.0 +/- 7.3 and 97.7 +/- 7.7 mm Hg, respectively. Follow-up BP was significantly higher in subgroups of patients with preexisting hypertension, baseline mean arterial pressure > 92 mm Hg, a diagnosis of polycystic kidney disease or glomerular diseases, baseline urinary protein excretion > 1 g/d, age greater or equal to 61 years, and black race. The frequency of medication changes and incidence of symptoms of low BP were greater in the low BP group, but there were no significant differences between BP groups in stop points, hospitalizations, or death. When data from both groups were combined, each 1-mm Hg increase in follow-up systolic BP was associated with a 1.35-times greater risk of hospitalization for cardiovascular or cerebrovascular disease. Lower BP than usually recommended for the prevention of cardiovascular disease is achievable by several medication regimens without serious adverse effects in patients with chronic renal disease without cardiovascular disease. For patients with urinary protein excretion > 1 g/d, target BP should be a mean arterial pressure of less or equal to 92 mm Hg, equivalent to 125/75 mm Hg. (Hypertension. 1997;29:641-650.) |
doi_str_mv | 10.1161/01.HYP.29.2.641 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_205284067</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>29063031</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3888-306bb43b0a84a3b592f6086fa7c76a87363523e2673add05e400f8de59343af3</originalsourceid><addsrcrecordid>eNpVkM9r2zAUx0XZ6NKs550GYuxqV78sy7t16ZoOMlbaHLqTkO0nrM6xUsleyHn_-BQSCnsgHk_v8_1KfBH6QElOqaRXhOZ3v-5zVuUsl4KeoRktmMhEIfkbNCO0EllF6dM7dBHjMyFUCFGeo_OKCCIKOkN_r5vOwR_YwDBiM7T40VgY99hbbPDK7_DX3vsW3weIcQqAl9702A140QU_uAY_wJAublwEE-ELXneAf_jWWdeY0fnh4HPjYDxI_kPx4zi1e7wMftq-R2-t6SNcnvocrW-_rRd32ern8vviepU1XCmVcSLrWvCaGCUMr4uKWUmUtKZsSmlUySUvGAcmS27alhQgCLGqhaLighvL5-jT0XYb_MsEcdTPfgrpT1EzUjAlSFLO0dURaoKPMYDV2-A2Juw1JfqQuCZUp8Q1qzTTKfGk-HiyneoNtK_8KeK0_3zam9iY3gYzNC6-YqxQqhSHh8UR2_l-hBB_99MOgu7A9GOnSSrBpMpoVZWEpSlLhyr-D57Llt4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>205284067</pqid></control><display><type>article</type><title>Achievement and Safety of a Low Blood Pressure Goal in Chronic Renal Disease: The Modification of Diet in Renal Disease Study Group</title><source>MEDLINE</source><source>American Heart Association Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Journals@Ovid Complete</source><creator>Lazarus, J. Michael ; Bourgoignie, Jacques J ; Buckalew, Vardaman M ; Greene, Tom ; Levey, Andrew S ; Milas, N. Carole ; Paranandi, Lata ; Peterson, John C ; Porush, Jerome G ; Rauch, Sally ; Soucie, J. Michael ; Stollar, Carol</creator><creatorcontrib>Lazarus, J. Michael ; Bourgoignie, Jacques J ; Buckalew, Vardaman M ; Greene, Tom ; Levey, Andrew S ; Milas, N. Carole ; Paranandi, Lata ; Peterson, John C ; Porush, Jerome G ; Rauch, Sally ; Soucie, J. Michael ; Stollar, Carol</creatorcontrib><description>The Modification of Diet in Renal Disease Study showed a beneficial effect of a lower-than-usual blood pressure (BP) goal on the progression of renal disease in patients with proteinuria. The purpose of the present analyses was to examine the achieved BP, baseline characteristics that helped or hindered achievement of the BP goals, and safety of the BP interventions. Five hundred eighty-five patients with baseline glomerular filtration rate between 13 and 55 mL/min per 1.73 m () (0.22 to 0.92 mL/s per 1.73 m) were randomly assigned to either a usual or low BP goal (mean arterial pressure less or equal to 107 or less or equal to 92 mm Hg, respectively). Few patients had a history of cardiovascular disease. All antihypertensive agents were permitted, but angiotensin-converting enzyme inhibitors (with or without diuretics) followed by calcium channel blockers were preferred. The mean (+/- SD) of the mean arterial pressures during follow-up in the low and usual BP groups was 93.0 +/- 7.3 and 97.7 +/- 7.7 mm Hg, respectively. Follow-up BP was significantly higher in subgroups of patients with preexisting hypertension, baseline mean arterial pressure > 92 mm Hg, a diagnosis of polycystic kidney disease or glomerular diseases, baseline urinary protein excretion > 1 g/d, age greater or equal to 61 years, and black race. The frequency of medication changes and incidence of symptoms of low BP were greater in the low BP group, but there were no significant differences between BP groups in stop points, hospitalizations, or death. When data from both groups were combined, each 1-mm Hg increase in follow-up systolic BP was associated with a 1.35-times greater risk of hospitalization for cardiovascular or cerebrovascular disease. Lower BP than usually recommended for the prevention of cardiovascular disease is achievable by several medication regimens without serious adverse effects in patients with chronic renal disease without cardiovascular disease. For patients with urinary protein excretion > 1 g/d, target BP should be a mean arterial pressure of less or equal to 92 mm Hg, equivalent to 125/75 mm Hg. (Hypertension. 1997;29:641-650.)</description><identifier>ISSN: 0194-911X</identifier><identifier>EISSN: 1524-4563</identifier><identifier>DOI: 10.1161/01.HYP.29.2.641</identifier><identifier>PMID: 9040451</identifier><identifier>CODEN: HPRTDN</identifier><language>eng</language><publisher>Philadelphia, PA: American Heart Association, Inc</publisher><subject>Adolescent ; Adult ; Aged ; Antihypertensive Agents - adverse effects ; Antihypertensive Agents - therapeutic use ; Biological and medical sciences ; Blood Pressure - drug effects ; Chronic Disease ; Diet, Protein-Restricted - adverse effects ; Female ; Follow-Up Studies ; Humans ; Hypertension - diagnosis ; Kidney Diseases - diet therapy ; Male ; Medical sciences ; Middle Aged ; Nephrology. Urinary tract diseases ; Nephropathies. Renovascular diseases. Renal failure ; Proteinuria - diagnosis ; Renal failure ; Safety</subject><ispartof>Hypertension (Dallas, Tex. 1979), 1997-02, Vol.29 (2), p.641-650</ispartof><rights>1997 American Heart Association, Inc.</rights><rights>1997 INIST-CNRS</rights><rights>Copyright American Heart Association, Inc. Feb 1997</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3888-306bb43b0a84a3b592f6086fa7c76a87363523e2673add05e400f8de59343af3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,3674,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2588747$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9040451$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lazarus, J. Michael</creatorcontrib><creatorcontrib>Bourgoignie, Jacques J</creatorcontrib><creatorcontrib>Buckalew, Vardaman M</creatorcontrib><creatorcontrib>Greene, Tom</creatorcontrib><creatorcontrib>Levey, Andrew S</creatorcontrib><creatorcontrib>Milas, N. Carole</creatorcontrib><creatorcontrib>Paranandi, Lata</creatorcontrib><creatorcontrib>Peterson, John C</creatorcontrib><creatorcontrib>Porush, Jerome G</creatorcontrib><creatorcontrib>Rauch, Sally</creatorcontrib><creatorcontrib>Soucie, J. Michael</creatorcontrib><creatorcontrib>Stollar, Carol</creatorcontrib><title>Achievement and Safety of a Low Blood Pressure Goal in Chronic Renal Disease: The Modification of Diet in Renal Disease Study Group</title><title>Hypertension (Dallas, Tex. 1979)</title><addtitle>Hypertension</addtitle><description>The Modification of Diet in Renal Disease Study showed a beneficial effect of a lower-than-usual blood pressure (BP) goal on the progression of renal disease in patients with proteinuria. The purpose of the present analyses was to examine the achieved BP, baseline characteristics that helped or hindered achievement of the BP goals, and safety of the BP interventions. Five hundred eighty-five patients with baseline glomerular filtration rate between 13 and 55 mL/min per 1.73 m () (0.22 to 0.92 mL/s per 1.73 m) were randomly assigned to either a usual or low BP goal (mean arterial pressure less or equal to 107 or less or equal to 92 mm Hg, respectively). Few patients had a history of cardiovascular disease. All antihypertensive agents were permitted, but angiotensin-converting enzyme inhibitors (with or without diuretics) followed by calcium channel blockers were preferred. The mean (+/- SD) of the mean arterial pressures during follow-up in the low and usual BP groups was 93.0 +/- 7.3 and 97.7 +/- 7.7 mm Hg, respectively. Follow-up BP was significantly higher in subgroups of patients with preexisting hypertension, baseline mean arterial pressure > 92 mm Hg, a diagnosis of polycystic kidney disease or glomerular diseases, baseline urinary protein excretion > 1 g/d, age greater or equal to 61 years, and black race. The frequency of medication changes and incidence of symptoms of low BP were greater in the low BP group, but there were no significant differences between BP groups in stop points, hospitalizations, or death. When data from both groups were combined, each 1-mm Hg increase in follow-up systolic BP was associated with a 1.35-times greater risk of hospitalization for cardiovascular or cerebrovascular disease. Lower BP than usually recommended for the prevention of cardiovascular disease is achievable by several medication regimens without serious adverse effects in patients with chronic renal disease without cardiovascular disease. For patients with urinary protein excretion > 1 g/d, target BP should be a mean arterial pressure of less or equal to 92 mm Hg, equivalent to 125/75 mm Hg. (Hypertension. 1997;29:641-650.)</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Antihypertensive Agents - adverse effects</subject><subject>Antihypertensive Agents - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Blood Pressure - drug effects</subject><subject>Chronic Disease</subject><subject>Diet, Protein-Restricted - adverse effects</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Hypertension - diagnosis</subject><subject>Kidney Diseases - diet therapy</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Nephrology. Urinary tract diseases</subject><subject>Nephropathies. Renovascular diseases. Renal failure</subject><subject>Proteinuria - diagnosis</subject><subject>Renal failure</subject><subject>Safety</subject><issn>0194-911X</issn><issn>1524-4563</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkM9r2zAUx0XZ6NKs550GYuxqV78sy7t16ZoOMlbaHLqTkO0nrM6xUsleyHn_-BQSCnsgHk_v8_1KfBH6QElOqaRXhOZ3v-5zVuUsl4KeoRktmMhEIfkbNCO0EllF6dM7dBHjMyFUCFGeo_OKCCIKOkN_r5vOwR_YwDBiM7T40VgY99hbbPDK7_DX3vsW3weIcQqAl9702A140QU_uAY_wJAublwEE-ELXneAf_jWWdeY0fnh4HPjYDxI_kPx4zi1e7wMftq-R2-t6SNcnvocrW-_rRd32ern8vviepU1XCmVcSLrWvCaGCUMr4uKWUmUtKZsSmlUySUvGAcmS27alhQgCLGqhaLighvL5-jT0XYb_MsEcdTPfgrpT1EzUjAlSFLO0dURaoKPMYDV2-A2Juw1JfqQuCZUp8Q1qzTTKfGk-HiyneoNtK_8KeK0_3zam9iY3gYzNC6-YqxQqhSHh8UR2_l-hBB_99MOgu7A9GOnSSrBpMpoVZWEpSlLhyr-D57Llt4</recordid><startdate>199702</startdate><enddate>199702</enddate><creator>Lazarus, J. Michael</creator><creator>Bourgoignie, Jacques J</creator><creator>Buckalew, Vardaman M</creator><creator>Greene, Tom</creator><creator>Levey, Andrew S</creator><creator>Milas, N. Carole</creator><creator>Paranandi, Lata</creator><creator>Peterson, John C</creator><creator>Porush, Jerome G</creator><creator>Rauch, Sally</creator><creator>Soucie, J. Michael</creator><creator>Stollar, Carol</creator><general>American Heart Association, Inc</general><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope></search><sort><creationdate>199702</creationdate><title>Achievement and Safety of a Low Blood Pressure Goal in Chronic Renal Disease: The Modification of Diet in Renal Disease Study Group</title><author>Lazarus, J. Michael ; Bourgoignie, Jacques J ; Buckalew, Vardaman M ; Greene, Tom ; Levey, Andrew S ; Milas, N. Carole ; Paranandi, Lata ; Peterson, John C ; Porush, Jerome G ; Rauch, Sally ; Soucie, J. Michael ; Stollar, Carol</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3888-306bb43b0a84a3b592f6086fa7c76a87363523e2673add05e400f8de59343af3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Antihypertensive Agents - adverse effects</topic><topic>Antihypertensive Agents - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Blood Pressure - drug effects</topic><topic>Chronic Disease</topic><topic>Diet, Protein-Restricted - adverse effects</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Hypertension - diagnosis</topic><topic>Kidney Diseases - diet therapy</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Nephrology. Urinary tract diseases</topic><topic>Nephropathies. Renovascular diseases. Renal failure</topic><topic>Proteinuria - diagnosis</topic><topic>Renal failure</topic><topic>Safety</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lazarus, J. Michael</creatorcontrib><creatorcontrib>Bourgoignie, Jacques J</creatorcontrib><creatorcontrib>Buckalew, Vardaman M</creatorcontrib><creatorcontrib>Greene, Tom</creatorcontrib><creatorcontrib>Levey, Andrew S</creatorcontrib><creatorcontrib>Milas, N. Carole</creatorcontrib><creatorcontrib>Paranandi, Lata</creatorcontrib><creatorcontrib>Peterson, John C</creatorcontrib><creatorcontrib>Porush, Jerome G</creatorcontrib><creatorcontrib>Rauch, Sally</creatorcontrib><creatorcontrib>Soucie, J. Michael</creatorcontrib><creatorcontrib>Stollar, Carol</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><jtitle>Hypertension (Dallas, Tex. 1979)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lazarus, J. Michael</au><au>Bourgoignie, Jacques J</au><au>Buckalew, Vardaman M</au><au>Greene, Tom</au><au>Levey, Andrew S</au><au>Milas, N. Carole</au><au>Paranandi, Lata</au><au>Peterson, John C</au><au>Porush, Jerome G</au><au>Rauch, Sally</au><au>Soucie, J. Michael</au><au>Stollar, Carol</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Achievement and Safety of a Low Blood Pressure Goal in Chronic Renal Disease: The Modification of Diet in Renal Disease Study Group</atitle><jtitle>Hypertension (Dallas, Tex. 1979)</jtitle><addtitle>Hypertension</addtitle><date>1997-02</date><risdate>1997</risdate><volume>29</volume><issue>2</issue><spage>641</spage><epage>650</epage><pages>641-650</pages><issn>0194-911X</issn><eissn>1524-4563</eissn><coden>HPRTDN</coden><abstract>The Modification of Diet in Renal Disease Study showed a beneficial effect of a lower-than-usual blood pressure (BP) goal on the progression of renal disease in patients with proteinuria. The purpose of the present analyses was to examine the achieved BP, baseline characteristics that helped or hindered achievement of the BP goals, and safety of the BP interventions. Five hundred eighty-five patients with baseline glomerular filtration rate between 13 and 55 mL/min per 1.73 m () (0.22 to 0.92 mL/s per 1.73 m) were randomly assigned to either a usual or low BP goal (mean arterial pressure less or equal to 107 or less or equal to 92 mm Hg, respectively). Few patients had a history of cardiovascular disease. All antihypertensive agents were permitted, but angiotensin-converting enzyme inhibitors (with or without diuretics) followed by calcium channel blockers were preferred. The mean (+/- SD) of the mean arterial pressures during follow-up in the low and usual BP groups was 93.0 +/- 7.3 and 97.7 +/- 7.7 mm Hg, respectively. Follow-up BP was significantly higher in subgroups of patients with preexisting hypertension, baseline mean arterial pressure > 92 mm Hg, a diagnosis of polycystic kidney disease or glomerular diseases, baseline urinary protein excretion > 1 g/d, age greater or equal to 61 years, and black race. The frequency of medication changes and incidence of symptoms of low BP were greater in the low BP group, but there were no significant differences between BP groups in stop points, hospitalizations, or death. When data from both groups were combined, each 1-mm Hg increase in follow-up systolic BP was associated with a 1.35-times greater risk of hospitalization for cardiovascular or cerebrovascular disease. Lower BP than usually recommended for the prevention of cardiovascular disease is achievable by several medication regimens without serious adverse effects in patients with chronic renal disease without cardiovascular disease. For patients with urinary protein excretion > 1 g/d, target BP should be a mean arterial pressure of less or equal to 92 mm Hg, equivalent to 125/75 mm Hg. (Hypertension. 1997;29:641-650.)</abstract><cop>Philadelphia, PA</cop><cop>Hagerstown, MD</cop><pub>American Heart Association, Inc</pub><pmid>9040451</pmid><doi>10.1161/01.HYP.29.2.641</doi><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0194-911X |
ispartof | Hypertension (Dallas, Tex. 1979), 1997-02, Vol.29 (2), p.641-650 |
issn | 0194-911X 1524-4563 |
language | eng |
recordid | cdi_proquest_journals_205284067 |
source | MEDLINE; American Heart Association Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Journals@Ovid Complete |
subjects | Adolescent Adult Aged Antihypertensive Agents - adverse effects Antihypertensive Agents - therapeutic use Biological and medical sciences Blood Pressure - drug effects Chronic Disease Diet, Protein-Restricted - adverse effects Female Follow-Up Studies Humans Hypertension - diagnosis Kidney Diseases - diet therapy Male Medical sciences Middle Aged Nephrology. Urinary tract diseases Nephropathies. Renovascular diseases. Renal failure Proteinuria - diagnosis Renal failure Safety |
title | Achievement and Safety of a Low Blood Pressure Goal in Chronic Renal Disease: The Modification of Diet in Renal Disease Study Group |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T03%3A16%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Achievement%20and%20Safety%20of%20a%20Low%20Blood%20Pressure%20Goal%20in%20Chronic%20Renal%20Disease:%20The%20Modification%20of%20Diet%20in%20Renal%20Disease%20Study%20Group&rft.jtitle=Hypertension%20(Dallas,%20Tex.%201979)&rft.au=Lazarus,%20J.%20Michael&rft.date=1997-02&rft.volume=29&rft.issue=2&rft.spage=641&rft.epage=650&rft.pages=641-650&rft.issn=0194-911X&rft.eissn=1524-4563&rft.coden=HPRTDN&rft_id=info:doi/10.1161/01.HYP.29.2.641&rft_dat=%3Cproquest_cross%3E29063031%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=205284067&rft_id=info:pmid/9040451&rfr_iscdi=true |